Lexicon Pharmaceuticals, Inc. earnings per share and revenue

LXRX earnings per share for the last quarter are -0.20 USD whereas the estimation was -0.22 USD which accounts for 7.91% surprise. Company revenue for the same period amounts to 702.00 k USD despite the estimated figure of 1.25 M USD. Estimated earnings per share for the next quarter are -0.18 USD, and revenue is expected to reach 1.40 M USD. Also watch annual changes over time to get a bigger picture of LXRX earnings per share and revenue dynamics.